Geode Capital Management LLC Sells 3,029 Shares of Cellebrite DI Ltd. (NASDAQ:CLBT)

Geode Capital Management LLC reduced its stake in Cellebrite DI Ltd. (NASDAQ:CLBT) by 1.3% during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 239,268 shares of the company’s stock after selling 3,029 shares during the period. Geode Capital Management LLC owned approximately 0.12% of Cellebrite DI worth $4,029,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in CLBT. Quarry LP purchased a new position in Cellebrite DI during the 3rd quarter valued at approximately $27,000. Point72 Asia Singapore Pte. Ltd. lifted its position in Cellebrite DI by 59.6% during the second quarter. Point72 Asia Singapore Pte. Ltd. now owns 2,724 shares of the company’s stock valued at $33,000 after purchasing an additional 1,017 shares during the last quarter. Advisors Asset Management Inc. grew its stake in shares of Cellebrite DI by 130.5% in the 3rd quarter. Advisors Asset Management Inc. now owns 3,077 shares of the company’s stock worth $52,000 after buying an additional 1,742 shares in the last quarter. Public Employees Retirement Association of Colorado purchased a new stake in shares of Cellebrite DI during the 2nd quarter valued at about $71,000. Finally, Pathway Financial Advisers LLC lifted its holdings in shares of Cellebrite DI by 1,583.8% in the 3rd quarter. Pathway Financial Advisers LLC now owns 4,378 shares of the company’s stock valued at $74,000 after acquiring an additional 4,118 shares during the last quarter. Institutional investors own 45.88% of the company’s stock.

Cellebrite DI Stock Up 2.0 %

CLBT opened at $22.10 on Monday. The stock’s fifty day moving average is $20.04 and its two-hundred day moving average is $16.88. The company has a market capitalization of $4.55 billion, a P/E ratio of -14.26, a PEG ratio of 2.71 and a beta of 1.51. Cellebrite DI Ltd. has a 52 week low of $7.91 and a 52 week high of $22.91.

Cellebrite DI (NASDAQ:CLBT) last announced its quarterly earnings results on Wednesday, November 6th. The company reported $0.14 EPS for the quarter, beating the consensus estimate of $0.09 by $0.05. Cellebrite DI had a positive return on equity of 122.59% and a negative net margin of 82.28%. The firm had revenue of $106.90 million for the quarter, compared to analyst estimates of $102.06 million. During the same quarter last year, the firm posted $0.09 earnings per share. The business’s revenue for the quarter was up 27.0% on a year-over-year basis. Equities analysts anticipate that Cellebrite DI Ltd. will post 0.32 earnings per share for the current year.

Wall Street Analyst Weigh In

Several analysts recently weighed in on the company. Needham & Company LLC increased their price target on Cellebrite DI from $17.00 to $21.00 and gave the company a “buy” rating in a report on Thursday, November 7th. Craig Hallum lifted their price target on shares of Cellebrite DI from $23.00 to $24.00 and gave the stock a “buy” rating in a research note on Thursday, November 7th. TD Cowen boosted their target price on Cellebrite DI from $20.00 to $23.00 and gave the company a “buy” rating in a research report on Monday, September 23rd. Finally, JPMorgan Chase & Co. upped their target price on Cellebrite DI from $22.00 to $24.00 and gave the company an “overweight” rating in a research note on Monday, December 16th. Eight equities research analysts have rated the stock with a buy rating, According to data from MarketBeat, the stock has a consensus rating of “Buy” and a consensus target price of $20.57.

About Cellebrite DI

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft.